Eurofins-Cerep SA
PAR:ALECR

Watchlist Manager
Eurofins-Cerep SA Logo
Eurofins-Cerep SA
PAR:ALECR
Watchlist
Price: 22 200 EUR 8.82% Market Closed
Market Cap: 111m EUR

Wall Street
Price Targets

ALECR Price Targets Summary
Eurofins-Cerep SA

There are no price targets for ALECR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Eurofins-Cerep SA Competitors:
Price Targets
SYNGENE
Syngene International Ltd
13% Upside
MCAP
MedCap AB (publ)
30% Upside
QGEN
Qiagen NV
10% Upside
1548
Genscript Biotech Corp
86% Upside
BIO
Bio Rad Laboratories Inc
45% Upside
DIVISLAB
Divi's Laboratories Ltd
5% Downside
688046
GemPharmatech Co Ltd
50% Upside
PSNL
Personalis Inc
52% Upside

Revenue
Forecast

Revenue Estimate
Eurofins-Cerep SA

Revenue forecast
is not available for
Eurofins-Cerep SA

Operating Income
Forecast

Operating Income Estimate
Eurofins-Cerep SA

Operating Income forecast
is not available for
Eurofins-Cerep SA

Net Income
Forecast

Net Income Estimate
Eurofins-Cerep SA

Net Income forecast
is not available for
Eurofins-Cerep SA
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALECR's stock price target?
Not Available

ALECR doesn't have any price targets made by Wall Street professionals.

Back to Top